managing hypercalcaemia presented on cmc, kol, 1.10.2013
TRANSCRIPT
![Page 1: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013](https://reader037.vdocuments.net/reader037/viewer/2022110118/554974f7b4c90595518b5732/html5/thumbnails/1.jpg)
MANAGING HYPERCALCEMIA
Speaker: Dr. Dibbendhu Khanra
Chairperson: Dr. A.K. Banerjee
![Page 2: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013](https://reader037.vdocuments.net/reader037/viewer/2022110118/554974f7b4c90595518b5732/html5/thumbnails/2.jpg)
- most over-the-counter sold drug
- 43% Indian women on
supplement
- prescribed by doctors commonly
most abundant mineral of body
maintenance of strong bones
neuro-mascular action
blood clotting, blood pressure
hormone regulation
Calcium an unparallel hero
![Page 3: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013](https://reader037.vdocuments.net/reader037/viewer/2022110118/554974f7b4c90595518b5732/html5/thumbnails/3.jpg)
3
Calcium- a sinister in disguise
Hypercalcaemia- Today’s concern!
..Some cases..
![Page 4: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013](https://reader037.vdocuments.net/reader037/viewer/2022110118/554974f7b4c90595518b5732/html5/thumbnails/4.jpg)
CASE 1
Mr. K is a 41 year old patient– Mild depression– Behavioral abnormality– Headache– Fatigue– Difficulty concentrating– TSH - 2.06 (0.5 – 4.00)– calcium 12.4 mg/dl
(8.4 – 10.4 mg/dl)
![Page 5: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013](https://reader037.vdocuments.net/reader037/viewer/2022110118/554974f7b4c90595518b5732/html5/thumbnails/5.jpg)
CASE 2
Mrs. C is a 57 year old patient, well
t-score – 1.3 (spine), 2. 8 (femur)
Calcium – 12. 5 (8.4 – 10.4 mg/dl)
weight loss and generalised weakness
Cough and hemoptysis
![Page 6: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013](https://reader037.vdocuments.net/reader037/viewer/2022110118/554974f7b4c90595518b5732/html5/thumbnails/6.jpg)
CASE 3
• A 58-year-woman presented to ER• progressive Multiple sclerosis• Osteoporosis• calcium, 600 mg, 3 times daily• 5000-IU cholecalciferol supplement OD• tremors• Altered sensorium• serum calcium 15.2 mg/dL
![Page 7: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013](https://reader037.vdocuments.net/reader037/viewer/2022110118/554974f7b4c90595518b5732/html5/thumbnails/7.jpg)
• 30-year-old female• Fever, cough• Polyuria, polydypsia, GI upset• constipation, confusion, headache• CECT chest – hilar lympahedenopathy• serum calcium, 13.8 mg/d
CASE 4
![Page 8: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013](https://reader037.vdocuments.net/reader037/viewer/2022110118/554974f7b4c90595518b5732/html5/thumbnails/8.jpg)
• 50-year-old male• Diabetic for 10 years• Poorly controlled with OHA• HTN, anasarca, anaemia• serum calcium 14.8 mg/d
CASE 5
We will come back to the cases..
![Page 9: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013](https://reader037.vdocuments.net/reader037/viewer/2022110118/554974f7b4c90595518b5732/html5/thumbnails/9.jpg)
Learning Objectives
Calcium metabolism Defining hypercalcaemia Causes of hypercalcaemia Cl/f of hypercalceimia Diagnosis to hypercalcaemia Management
![Page 10: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013](https://reader037.vdocuments.net/reader037/viewer/2022110118/554974f7b4c90595518b5732/html5/thumbnails/10.jpg)
10
Calcium Metabolism
![Page 11: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013](https://reader037.vdocuments.net/reader037/viewer/2022110118/554974f7b4c90595518b5732/html5/thumbnails/11.jpg)
11
Defining Hypercalcemia
![Page 12: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013](https://reader037.vdocuments.net/reader037/viewer/2022110118/554974f7b4c90595518b5732/html5/thumbnails/12.jpg)
Defining Hypercalcemia
![Page 13: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013](https://reader037.vdocuments.net/reader037/viewer/2022110118/554974f7b4c90595518b5732/html5/thumbnails/13.jpg)
13
![Page 14: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013](https://reader037.vdocuments.net/reader037/viewer/2022110118/554974f7b4c90595518b5732/html5/thumbnails/14.jpg)
Ca+
+
PTH
Vitamin D
MalignancyMedicines
Endocrine
Genetic
Causes
![Page 15: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013](https://reader037.vdocuments.net/reader037/viewer/2022110118/554974f7b4c90595518b5732/html5/thumbnails/15.jpg)
Clinical features
15
Renal ‘stone
’
Abdominal
‘moan’
Skeletal
‘bone’
Psychis
‘groan’
Also…
![Page 16: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013](https://reader037.vdocuments.net/reader037/viewer/2022110118/554974f7b4c90595518b5732/html5/thumbnails/16.jpg)
Clinical features (Cont.)
Digitalis toxicity
![Page 17: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013](https://reader037.vdocuments.net/reader037/viewer/2022110118/554974f7b4c90595518b5732/html5/thumbnails/17.jpg)
A = high calcium levels means primary hyperparathyroidism unless the PTH is near zero
B = normocalcemic" hyperparathyroidism.this is the only group that we believe should
have a urinary calcium level performed
![Page 18: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013](https://reader037.vdocuments.net/reader037/viewer/2022110118/554974f7b4c90595518b5732/html5/thumbnails/18.jpg)
It is IMPOSSIBLE to tell the difference between FHH and primary hyperparathyroidism
based upon the results of a 24-hour urine test
1. Urinary calcium can be anything (very low to very high) in Pr HyperPTHism.
2. The arbitrary cut off of urinary ca excretion/ 24 hr 100 lacks any rationality.
3. Nor elevated serum ca neither elevated urinary ca has any association with renal stones.
4. Low urinary ca does not always mean FHH.
FHH is so rare, that few doctors will ever see it. FHH is diagnosed incorrectly about 95-99% of the time
![Page 19: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013](https://reader037.vdocuments.net/reader037/viewer/2022110118/554974f7b4c90595518b5732/html5/thumbnails/19.jpg)
19
Diagnostic Approach
Sestamibi N-scan
Familial Hypocalciuric Hypercalcemi
a
calcium is high and PTH is high, d/g is primary hyperparathyroidism.
IF calcium is mildly raised in background of highly elevated PTH, then urinary ca can be ordered to rule out FHH
Corrected serum calcium=Ionized calcium + 0.8(4-serum albumin)
![Page 20: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013](https://reader037.vdocuments.net/reader037/viewer/2022110118/554974f7b4c90595518b5732/html5/thumbnails/20.jpg)
CASE 1
Neuropsychiatric complaints
Calcium 12.4 mg/dl
iPTH – 509 (12-72 pg/ml)
Thallium subtraction study: Left lower lobe parathyroid adenoma
![Page 21: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013](https://reader037.vdocuments.net/reader037/viewer/2022110118/554974f7b4c90595518b5732/html5/thumbnails/21.jpg)
CASE 2
Weight loss and generalised weakness
Calcium – 12. 5 (8.4 – 10.4 mg/dl)
iPTH 21 (10 – 65.0 pg/ml)
PTHrp - elevated
Lung biopsy with IHC:Well differentiated, low grade squamous cell lung carcinoma
![Page 22: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013](https://reader037.vdocuments.net/reader037/viewer/2022110118/554974f7b4c90595518b5732/html5/thumbnails/22.jpg)
• calcium, cholecalciferol supplement• serum calcium14.6 mg/dL (15.2 mg/dL)• iPTH - 4 pg/mL (N12-65 pg/mL• 25-OH D level 103 ng/mL (N>30 ng/ml)
22
CASE 3
Vit D overdose
![Page 23: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013](https://reader037.vdocuments.net/reader037/viewer/2022110118/554974f7b4c90595518b5732/html5/thumbnails/23.jpg)
• CECT chest – hilar lympahedenopathy• serum calcium, 13.8 mg/d• iPTH - 4 pg/mL (N12-65 pg/mL• 1, 25-OH D level elevated• Serum ACEase – highly raised
23
CASE 4
Hilar LN Bx – non caseating granulomasSarcoidosis
![Page 24: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013](https://reader037.vdocuments.net/reader037/viewer/2022110118/554974f7b4c90595518b5732/html5/thumbnails/24.jpg)
• T2DM• CKD• serum calcium 14.8 mg/d• iPTH – 209 (12-72 pg/ml)
CASE 5
Hypercalcemia Associated with Renal Failure
![Page 25: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013](https://reader037.vdocuments.net/reader037/viewer/2022110118/554974f7b4c90595518b5732/html5/thumbnails/25.jpg)
25
Hypocalcaemia is the common denominator Reversible (adaptive) growth of parathyroid gland
• Resistance to the normal level of PTH• Increased level of FGF23• Reduction in 1,25(OH)2 vitamin D
Hypercalcemia Associated with Renal Failure
Secondary Hyperparathyroidism
Tertiary Hyperparathyroidism
• Long-standing, inadequately treated chronic renal failure• True clonal outgrowth (irreversible)
![Page 26: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013](https://reader037.vdocuments.net/reader037/viewer/2022110118/554974f7b4c90595518b5732/html5/thumbnails/26.jpg)
TREATMENT
Observation
Pharmacological
NonPharmacological
Surgery
Dialysis
![Page 27: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013](https://reader037.vdocuments.net/reader037/viewer/2022110118/554974f7b4c90595518b5732/html5/thumbnails/27.jpg)
Hypercalcemia: to treat or not to
27
Critical - > 14 mg %
Moderate - 12 to 14 mg %
Mild – 10.4 to 11.9 mg %
Normal – 8.5 to 10.3 mg %
1 • Aggressive therapy
2
• Start therapy• When
symptomatic• When
PrHyperPTHism
3• No therapy• Except
PrHyperPTHism
Hypercalcaemia should always be treated
![Page 28: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013](https://reader037.vdocuments.net/reader037/viewer/2022110118/554974f7b4c90595518b5732/html5/thumbnails/28.jpg)
Avoid factors that can aggravate hypercalcemia
28
- thiazide and lithium- volume depletion- prolonged bed rest or inactivity- high calcium diet (>1000 mg/day)
![Page 29: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013](https://reader037.vdocuments.net/reader037/viewer/2022110118/554974f7b4c90595518b5732/html5/thumbnails/29.jpg)
The Four Rx Modalities
I.V. Saline Hydration
Dexamethason
e
Bisphos- phonate
s
Calcitonin
29
A
B C
D
![Page 30: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013](https://reader037.vdocuments.net/reader037/viewer/2022110118/554974f7b4c90595518b5732/html5/thumbnails/30.jpg)
Dr. Harold Copp isolated calcitonin from salmon sperm
![Page 31: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013](https://reader037.vdocuments.net/reader037/viewer/2022110118/554974f7b4c90595518b5732/html5/thumbnails/31.jpg)
Bisphosphonate:
MOA
Osteonecrosis of Jaw (ONJ)
mandible > maxilla Matrix metalloproteinase 2
![Page 32: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013](https://reader037.vdocuments.net/reader037/viewer/2022110118/554974f7b4c90595518b5732/html5/thumbnails/32.jpg)
In HF, CKD; lowers ca by 1-3 mg/dl
Routine use not recommended
Calcitonin and hydration provide a rapid reduction, while a bisphosphonate provides a sustained effect
Do not give bisphosphonates until patient is fully rehydratedcontraindicated in patients with cr cl <10 mL/min
Caution with NSAIDS, ACE inhibitors, aminoglycosides
Treating hypercalcaemia is multidrug approach
![Page 33: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013](https://reader037.vdocuments.net/reader037/viewer/2022110118/554974f7b4c90595518b5732/html5/thumbnails/33.jpg)
Monitoring
Mildly elevated calcium
No previous episodes of life threatening hypercalcemia
Normal renal function Normal bone status
Surgery• Serum calcium level
> 1 mg % above normal• Creatinine clearance
< 60 ml/minute• Bone density: T score <–
2.5
at Any of 3 sites• Age younger than 50
years33
Asymptomatic patient ofParathyroid adenoma
Serum caserum creatinine
Bone density
Significant symptoms – Rx surgery
![Page 34: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013](https://reader037.vdocuments.net/reader037/viewer/2022110118/554974f7b4c90595518b5732/html5/thumbnails/34.jpg)
Surgical TherapyMinimally Invasive Parathyroidectomy (MIP)
an outpatient procedure Pre-op localization with Sestamibi Tc scan cervical block anesthesia minimal surgical incision Intra-op PTH level obtained before and 5 mins after removal If PTH levels fall by greater than 50% operation terminated IF PTH Levels fall by less than 50%, full neck exploration clear-cut cost benefit Accepted in asymptomatic patients not proper for multiple tumour or large tumours
![Page 35: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013](https://reader037.vdocuments.net/reader037/viewer/2022110118/554974f7b4c90595518b5732/html5/thumbnails/35.jpg)
• If an enlarged gland is found, a normal gland should be sought.
• if an intra-operative frozen section biopsy of a normal-sized second gland confirms its histologic normality, no further exploration, biopsy, or excision is needed.
• recurrence rate of hyper-parathyroidism may be high if a second abnormal gland is missed.
• all four glands be sought
• most of the total parathyroid tissue mass be removed.
• unnecessary surgery & un-acceptable rate of hypoparathyroidism and hypocalcamia.
35
SURGICAL THERAPY (cont.)
Conventional
![Page 36: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013](https://reader037.vdocuments.net/reader037/viewer/2022110118/554974f7b4c90595518b5732/html5/thumbnails/36.jpg)
Surgery for MEN syndrome Conventional
• totally remove three glands with partial excision of the fourth gland
• care is taken to leave a good blood supply for the remaining gland
• total parathyroidectomy with immediate transplantation of a portion of a removed, minced parathyroid gland into the muscles of the forearm
• surgical excision is easier from the ectopic site in the arm if there is recurrent hyperfunction
36
![Page 37: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013](https://reader037.vdocuments.net/reader037/viewer/2022110118/554974f7b4c90595518b5732/html5/thumbnails/37.jpg)
CASE 1
calcium 12.4 mg/dl
(8.4 – 10.4 mg/dl)
parathyroid adenoma
M/N= Surgery (MIP)
![Page 38: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013](https://reader037.vdocuments.net/reader037/viewer/2022110118/554974f7b4c90595518b5732/html5/thumbnails/38.jpg)
CASE 2
Malignancy related hypercalcaemia
(Breast, Lung, Lymphoma, Thyroid, Kidney, Prostate, Multiple Myeloma)
N Saline calcitonin Zoledronic acid
![Page 39: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013](https://reader037.vdocuments.net/reader037/viewer/2022110118/554974f7b4c90595518b5732/html5/thumbnails/39.jpg)
39
CASE 3
• Vit D overdose• Half life of Vit D is very short
no further treatment required• Withhold Vit D• Steroid can be used
![Page 40: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013](https://reader037.vdocuments.net/reader037/viewer/2022110118/554974f7b4c90595518b5732/html5/thumbnails/40.jpg)
• Acute symptomatic hypercalcaemia• Sarcoidosis (granulomatous disease; DHCC
related)• NS• Steroid
40
CASE 4
![Page 41: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013](https://reader037.vdocuments.net/reader037/viewer/2022110118/554974f7b4c90595518b5732/html5/thumbnails/41.jpg)
• Hypercalcemia Associated with Renal Failure• Secondary hyperparathyroidism• calcitriol
CASE 5
![Page 42: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013](https://reader037.vdocuments.net/reader037/viewer/2022110118/554974f7b4c90595518b5732/html5/thumbnails/42.jpg)
Hypercalcemia Associated with Renal Failure
• Dialysis if life threatening
Secondary hyperparatyroidism• restriction of dietary phosphate, • the use of non-absorbable antacids• careful, selective addition of calcitriol
Tertiary Hyperparatyroidism• Partial removal of parathyroid gland
42
![Page 43: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013](https://reader037.vdocuments.net/reader037/viewer/2022110118/554974f7b4c90595518b5732/html5/thumbnails/43.jpg)
43
In CKD
Dialysis Controversial
Malignancy or Vit D associated cases
Avoid factors that can
aggravate hypercalcemia
SUMMARY
![Page 44: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013](https://reader037.vdocuments.net/reader037/viewer/2022110118/554974f7b4c90595518b5732/html5/thumbnails/44.jpg)
Take home messages
• Most common cause of hypercalcaemia is primary hyperparathyroidism
• Any hypercalcaemia should be worked up and treated. • First investigation to seek for is an intact PTH• Surgery is often provided to apparently aysmptomtic
patients of primary hyperparathyroidism• FHH, practically does NOT occur• Hydration is the mainstay of therapy• Managing hypercalcaemia is a multidrug approach• Calcitriol can be given in CKD associated hypercalaemia